HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

James J Vredenburgh Selected Research

bevacizumab

10/2015CCR 20th Anniversary Commentary: Bevacizumab in the Treatment of Glioblastoma--The Progress and the Limitations.
7/2015Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma.
8/2013Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial.
4/2013Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.
8/2012Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.
6/2012Stereotactic radiosurgery and bevacizumab for recurrent glioblastoma multiforme.
4/2012Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
3/2012Bevacizumab and daily temozolomide for recurrent glioblastoma.
3/2012Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients.
3/2012Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


James J Vredenburgh Research Topics

Disease

36Glioblastoma (Glioblastoma Multiforme)
10/2015 - 01/2004
32Neoplasms (Cancer)
10/2015 - 01/2002
32Glioma (Gliomas)
10/2015 - 01/2006
8Breast Neoplasms (Breast Cancer)
02/2006 - 01/2002
5Brain Neoplasms (Brain Tumor)
02/2012 - 01/2006
5Infection
01/2010 - 08/2002
4Diarrhea
07/2012 - 01/2004
4Astrocytoma (Pilocytic Astrocytoma)
10/2011 - 01/2006
3Fatigue
07/2012 - 12/2010
3Anoxia (Hypoxia)
04/2011 - 01/2008
2Lymphoma (Lymphomas)
08/2013 - 06/2004
2Meningioma (Meningiomas)
08/2012 - 01/2012
2Lymphopenia (Lymphocytopenia)
09/2011 - 03/2011
2Hypersensitivity (Allergy)
03/2011 - 11/2010
2Medulloblastoma
10/2008 - 07/2007
2Carcinoma (Carcinomatosis)
07/2003 - 06/2002
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2003 - 02/2003
1Disease Progression
10/2015
1Tetanus
03/2015
1Diphtheria
03/2015
1Status Epilepticus (Complex Partial Status Epilepticus)
02/2012
1Tuberous Sclerosis (Bourneville's Disease)
10/2011
1Posterior Leukoencephalopathy Syndrome
10/2011
1Melanoma (Melanoma, Malignant)
09/2011
1Hepatocellular Carcinoma (Hepatoma)
01/2011
1Striae Distensae
01/2011
1Exanthema (Rash)
12/2010
1Mucositis
12/2010
1Residual Neoplasm
11/2010
1Paraganglioma (Paragangliomas)
07/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2009

Drug/Important Bio-Agent (IBA)

26bevacizumabFDA Link
10/2015 - 02/2007
20temozolomide (Temodar)FDA LinkGeneric
07/2015 - 04/2007
15irinotecan (Camptosar)FDA LinkGeneric
10/2015 - 02/2007
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 01/2008
9Epidermal Growth Factor Receptor (EGF Receptor)IBA
07/2012 - 01/2004
7Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2012 - 01/2004
7Carmustine (FIVB)FDA Link
08/2009 - 01/2002
6imatinib (Gleevec)FDA Link
10/2012 - 12/2005
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2005 - 01/2002
5Hydroxyurea (Hydrea)FDA LinkGeneric
10/2012 - 12/2005
5Phosphotransferases (Kinase)IBA
07/2012 - 02/2006
5Cisplatin (Platino)FDA LinkGeneric
09/2005 - 01/2002
4erlotinib (CP 358,774)FDA Link
07/2012 - 01/2010
4epidermal growth factor receptor VIIIIBA
01/2012 - 01/2010
4O(6)-benzylguanineIBA
10/2009 - 02/2009
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2011 - 05/2009
3Sirolimus (Rapamycin)FDA Link
10/2011 - 02/2006
3tyrosine receptor (receptor, tyrosine)IBA
01/2010 - 02/2006
2VaccinesIBA
03/2015 - 05/2008
2AntigensIBA
03/2015 - 08/2002
2Proteins (Proteins, Gene)IBA
07/2012 - 10/2011
2Angiogenesis InhibitorsIBA
06/2012 - 04/2011
2Carboplatin (JM8)FDA LinkGeneric
03/2012 - 12/2011
2Etoposide (VP 16)FDA LinkGeneric
06/2011 - 03/2003
2Anticonvulsants (Antiepileptic Drugs)IBA
10/2010 - 02/2006
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2010 - 08/2008
2DNA (Deoxyribonucleic Acid)IBA
02/2009 - 05/2008
2Monoclonal AntibodiesIBA
05/2008 - 07/2007
2laromustine (VNP40101M)IBA
07/2007 - 01/2007
2Adenosine Triphosphate (ATP)IBA
05/2007 - 12/2005
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
05/2007 - 12/2005
2gefitinib (Iressa)FDA Link
02/2006 - 01/2004
2Alkylating AgentsIBA
02/2006 - 03/2002
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2005 - 04/2002
1PlatinumIBA
10/2015
1RNA (Ribonucleic Acid)IBA
03/2015
1cytomegalovirus matrix protein 65kDaIBA
03/2015
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
03/2015
1Adenocarcinoma of lungIBA
03/2015
1dasatinib (BMS 354825)FDA Link
07/2012
1pregabalin (Lyrica)FDA Link
02/2012
1etiracetam (levetiracetam)FDA LinkGeneric
02/2012
1Phenytoin (Dilantin)FDA LinkGeneric
02/2012
1BenzodiazepinesIBA
02/2012
1Prostaglandins B (PGB)IBA
02/2012
1Interleukin-2 (IL2)IBA
01/2012
1daclizumab (dacliximab)FDA Link
01/2012
1TransferasesIBA
12/2011
1sunitinib (Sutent)FDA Link
12/2011
1lonafarnib (SCH 66336)IBA
12/2011
1TabletsIBA
10/2011
1everolimusFDA Link
10/2011
1Interleukin-2 Receptors (IL 2 Receptor)IBA
09/2011
1sorafenib (BAY 43-9006)FDA Link
01/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2011
1O(6)-Methylguanine-DNA MethyltransferaseIBA
12/2009
1tinzaparin (Innohep)FDA Link
10/2009

Therapy/Procedure

26Drug Therapy (Chemotherapy)
10/2015 - 01/2002
5Radiotherapy
06/2012 - 06/2002
5Stem Cell Transplantation
08/2004 - 01/2002
4Salvage Therapy
03/2012 - 02/2007
3Immunotherapy
01/2012 - 05/2008
3Transplants (Transplant)
08/2004 - 01/2002
2Heterologous Transplantation (Xenotransplantation)
02/2009 - 07/2007
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2006 - 07/2003
2Transplantation (Transplant Recipients)
07/2003 - 04/2002
1Computer-Assisted Surgery (Image Guided Surgery)
06/2012
1Retreatment
10/2011
1Therapeutics
04/2011